Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data

Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disorder of the central nervous system. Disease-modifying drugs (DMDs) and subsequent adherence are crucial for preventing reversible episodes of neurological dysfunction and delayed onset of progressive accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauer, Larissa, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663167/
https://www.ncbi.nlm.nih.gov/pubmed/36388086
http://dx.doi.org/10.2147/DDDT.S236926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663167/
https://www.ncbi.nlm.nih.gov/pubmed/36388086
http://dx.doi.org/10.2147/DDDT.S236926

Ejemplares similares